S Sallah

Summary

Affiliation: University of Tennessee
Country: USA

Publications

  1. ncbi request reprint Venous thrombosis in patients with solid tumors: determination of frequency and characteristics
    Sabah Sallah
    Division of Hematology Oncology, University of Tennessee Health Science Center, Memphis 38103, USA
    Thromb Haemost 87:575-9. 2002
  2. ncbi request reprint Disseminated intravascular coagulation in solid tumors: clinical and pathologic study
    S Sallah
    Department of Medicine, University of Tennessee Health Science Center, Memphis 38103, USA
    Thromb Haemost 86:828-33. 2001
  3. ncbi request reprint Autoimmune hemolytic anemia in patients with non-Hodgkin's lymphoma: characteristics and significance
    S Sallah
    Department of Medicine, University of Tennessee, Memphis 38163, USA
    Ann Oncol 11:1571-7. 2000
  4. ncbi request reprint Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients
    S Sallah
    Department of Medicine, Division of Hematology Oncology, University of Tennessee, Memphis, Tennessee 38103, USA
    Cancer 91:1067-74. 2001
  5. ncbi request reprint Future development of lymphoproliferative disorders in patients with autoimmune hemolytic anemia
    S Sallah
    Division of Hematology Oncology, University of Tennessee Health Science Center, Memphis, Tennessee 38103, USA
    Clin Cancer Res 7:791-4. 2001
  6. ncbi request reprint Treatment of refractory T-cell malignancies using gemcitabine
    S Sallah
    Department of Medicine, Division of Hematology Oncology, University of Tennessee Health Science Center, Memphis, TN 38103, USA
    Br J Haematol 113:185-7. 2001
  7. ncbi request reprint Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting: a follow-up study
    S Sallah
    Department of Medicine, Division of Hematology Oncology, University of Tennessee, Memphis, Tennessee 38103, USA
    Cancer 92:1349-53. 2001
  8. ncbi request reprint The role of 2-chlorodeoxyadenosine in the treatment of patients with refractory angioimmunoblastic lymphadenopathy with dysproteinemia
    S Sallah
    Division of Hematology Oncology, East Carolina University, Greenville, NC 27858, USA
    Br J Haematol 104:163-5. 1999
  9. ncbi request reprint Reversion of primary hyperfibrinogenolysis in patients with hormone-refractory prostate cancer using docetaxel
    S Sallah
    Department of Medicine, University of Tennessee, Memphis, USA
    Cancer Invest 18:191-6. 2000
  10. ncbi request reprint Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation
    Sabah Sallah
    Thrombosis and Hemostasis Program and Feist Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71103, USA
    Blood Coagul Fibrinolysis 15:577-82. 2004

Detail Information

Publications12

  1. ncbi request reprint Venous thrombosis in patients with solid tumors: determination of frequency and characteristics
    Sabah Sallah
    Division of Hematology Oncology, University of Tennessee Health Science Center, Memphis 38103, USA
    Thromb Haemost 87:575-9. 2002
    ..Also, we evaluated the impact of VTD on the survival of these patients...
  2. ncbi request reprint Disseminated intravascular coagulation in solid tumors: clinical and pathologic study
    S Sallah
    Department of Medicine, University of Tennessee Health Science Center, Memphis 38103, USA
    Thromb Haemost 86:828-33. 2001
    ..The occurrence of DIC appears to have an independent effect on survival of patients with cancer. Cooperative studies are encouraged to better address the usefulness and optimal prophylactic heparin regimen in patients at risk for DIC...
  3. ncbi request reprint Autoimmune hemolytic anemia in patients with non-Hodgkin's lymphoma: characteristics and significance
    S Sallah
    Department of Medicine, University of Tennessee, Memphis 38163, USA
    Ann Oncol 11:1571-7. 2000
    ..However, there is lack of information in the literature in terms of the significance and impact of such phenomenon on the clinical course of these patients...
  4. ncbi request reprint Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients
    S Sallah
    Department of Medicine, Division of Hematology Oncology, University of Tennessee, Memphis, Tennessee 38103, USA
    Cancer 91:1067-74. 2001
    ..However, to the authors' knowledge there is lack of information in the literature with respect to the clinical course of these patients and the nature of the association between malignant tumors and acquired hemophilia...
  5. ncbi request reprint Future development of lymphoproliferative disorders in patients with autoimmune hemolytic anemia
    S Sallah
    Division of Hematology Oncology, University of Tennessee Health Science Center, Memphis, Tennessee 38103, USA
    Clin Cancer Res 7:791-4. 2001
    ....
  6. ncbi request reprint Treatment of refractory T-cell malignancies using gemcitabine
    S Sallah
    Department of Medicine, Division of Hematology Oncology, University of Tennessee Health Science Center, Memphis, TN 38103, USA
    Br J Haematol 113:185-7. 2001
    ..These encouraging results warrant further investigation of gemcitabine either as a single agent or in combination regimens as early salvage treatment for patients with refractory T-cell haematological neoplasms...
  7. ncbi request reprint Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting: a follow-up study
    S Sallah
    Department of Medicine, Division of Hematology Oncology, University of Tennessee, Memphis, Tennessee 38103, USA
    Cancer 92:1349-53. 2001
    ..Although some general risk factors are known to predispose to systemic fungal infections, few studies have addressed the relevance of certain clinical and laboratory features in patients with CDC...
  8. ncbi request reprint The role of 2-chlorodeoxyadenosine in the treatment of patients with refractory angioimmunoblastic lymphadenopathy with dysproteinemia
    S Sallah
    Division of Hematology Oncology, East Carolina University, Greenville, NC 27858, USA
    Br J Haematol 104:163-5. 1999
    ..Phase II studies evaluating the efficacy of this agent as front-line treatment for AILD are justified, especially in the absence of any effective therapy for this disorder...
  9. ncbi request reprint Reversion of primary hyperfibrinogenolysis in patients with hormone-refractory prostate cancer using docetaxel
    S Sallah
    Department of Medicine, University of Tennessee, Memphis, USA
    Cancer Invest 18:191-6. 2000
    ..Although this response appears to be due to antitumor activity, a direct effect on the fibrinolytic pathway induced by the tumor cannot be excluded. Further work in this area is warranted...
  10. ncbi request reprint Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation
    Sabah Sallah
    Thrombosis and Hemostasis Program and Feist Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71103, USA
    Blood Coagul Fibrinolysis 15:577-82. 2004
    ..Our data provide evidence that rFVIIa can be used successfully to control the hemorrhagic episodes associated with DIC. Although this type of treatment appears to be safe, close monitoring of the patients is warranted...
  11. ncbi request reprint Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy
    Sabah Sallah
    Thrombosis and Hemostasis Program and Feist Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71103, USA
    Clin Cancer Res 10:7238-43. 2004
    ..To correlate the concentration of plasma coagulation markers at baseline and during follow-up in patients with solid tumors and venous thromboembolic disease with the risk of recurrence and death...
  12. ncbi request reprint Aspiration occurence during chemoradiation for head and neck cancer
    Nam P Nguyen
    Department of Radiation Oncology, University of Arizona, Tucson, AZ 85724 5081, USA
    Anticancer Res 27:1669-72. 2007
    ..To assess the risk of developing aspiration during chemoradiation for head and neck cancer...